Sci­en­tist-turned-VC: Kevin Bit­ter­man takes his biotech hatch­ing ex­pe­ri­ence to a new role at At­las

Kevin Bit­ter­man knows a thing or two about biotech star­tups.

As a part­ner at Po­laris, which spe­cial­izes in cre­at­ing cut­ting edge de­vel­op­ers, he was the found­ing CEO of Ed­i­tas $ED­IT, one of the lead­ers in the gene edit­ing field. He was present at the cre­ation of Mor­phic and co-found­ed Geno­cea $GN­CA, among oth­ers.

And now he tells us he is mov­ing over to At­las Ven­ture, which plays a high pro­file role in kick­start­ing its own biotech ven­tures with a care­ful eye on the po­ten­tial pay­out.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER